The CDC’s Latest Updates on COVID-19 Vaccinations (2025)

The CDC’s Latest Updates on COVID-19 Vaccinations (2025)

As we move into the 2025 respiratory virus season, the Centers for Disease Control and Prevention (CDC) has introduced several key updates and shifts to COVID-19 vaccine policy. These changes reflect evolving science, politics, and public health considerations. Below is a breakdown of what’s new—and what remains the same—so you can stay informed.

---

What Remains: Core Recommendations for 2024–2025

Before recent shifts, the CDC’s guidance for the 2024–2025 COVID-19 vaccine season included the following:

• Everyone ages 6 months and older was recommended to get the updated 2024–2025 COVID-19 vaccine. CDC+2CDC+2
• The update was especially encouraged for older adults (65+), high-risk individuals, and those who had never received a COVID-19 vaccine. CDC
• For people 65 and older, the CDC recommended two doses of the 2024–2025 vaccine (i.e. a booster) to better sustain protection. CDC
• Those with moderate or severe immunocompromise could receive additional doses beyond the standard schedule, guided by healthcare providers. paltmed.org+4CDC+4CDC+4
• The CDC’s Interim Clinical Considerations (last updated May 1, 2025) organized detailed guidance for clinicians, though they state vaccine schedules haven’t drastically changed. CDC
• The CDC also aligned with the FDA’s plan for the 2025–2026 COVID-19 vaccines: new monovalent vaccines targeting the JN.1 lineage (in some cases with an LP.8.1 strain component) to match currently circulating variants. U.S. Food and Drug Administration

So, prior to the latest shifts, the baseline message was: “stay up to date” with COVID-19 vaccination, especially for higher-risk groups.

---

What’s New: Changing the Recommendation Landscape (2025)

In 2025, several major changes have rocked the CDC’s vaccine recommendations, creating confusion, debate, and real-world implications.

1. Movement Away from Universal COVID Vaccine Recommendation

One of the biggest shifts: the CDC no longer broadly recommends COVID-19 vaccination for all children and pregnant women. This change originated from a controversial directive by Health Secretary Robert F. Kennedy Jr., who removed those groups from the recommended immunization schedule. STAT+2Fierce Pharma+2

Children (especially healthy ones) and pregnant people now fall under “shared clinical decision-making” instead of a blanket recommendation. CBS News+3HHS.gov+3New England Journal of Medicine+3

2. “Shared Decision-Making” Replaces Universal Guidance

Rather than telling everyone 6 months and older to get vaccinated, the new approach emphasizes individualized consultation between patients and their healthcare providers. The Advisory Committee on Immunization Practices (ACIP) recommends this more personalized method, especially for those under age 65 without major risk factors. CDC+3HHS.gov+3New England Journal of Medicine+3

3. Divergence Among Expert Groups

Medical societies have responded differently:

• The American Academy of Pediatrics (AAP) continues to recommend COVID-19 vaccination for children aged 6 months to 23 months, diverging from CDC’s withdrawn universal recommendation. PBS+1
• American College of Obstetricians and Gynecologists (ACOG) still supports vaccination for pregnant and breastfeeding individuals. TIME+1
• Many states are stepping in to maintain access, coverage, or mandate measures in response to shifts at the federal level. opb+3TIME+3CT.gov+3

This discrepancy between federal guidance and expert bodies has created confusion for providers and the public.

4. Adjustments to Pediatric Vaccine Schedule

The CDC, as part of its recent updates, now recommends separating the MMR (measles-mumps-rubella) and varicella (chickenpox) shots for children under four, rather than using the combined MMRV vaccine, citing concerns about febrile seizures. Politico+2The Guardian+2

This change, though not strictly a COVID update, is part of broader adjustments in the immunization schedule under new advisory influence.

5. Vaccine Access, Policy, and Insurance Uncertainty

Because the CDC’s recommendations often shape insurance coverage and vaccine program logistics, the shifts have consequences:

• Some states (e.g. Arizona, Colorado, Connecticut) have issued their own policies to preserve vaccine access. TIME+1
• Pharmacies like CVS and Walgreens have reported policy and eligibility adjustments, citing stricter federal criteria. Fierce Healthcare
• Some health departments (e.g. New Mexico) say they will continue to follow previous guidance until official updates are fully integrated. KOAT

---

What the CDC Still Emphasizes

Amid changes, the CDC maintains certain core messages:

• COVID-19 vaccines still help reduce severe illness, hospitalization, and death. CDC+2CDC+2
• Vaccination is especially important for older adults (65+), immunocompromised individuals, or those with underlying conditions. CDC+2CDC+2
• The updated 2024–2025 COVID-19 vaccines are still recommended for the general population, including people who have already had COVID-19. CDC+2CDC+2
• If someone recently had COVID-19, they may delay vaccination for up to 3 months after symptom onset or positive test. CDC+2CDC+2

---

What You Should Know: 2025 Fall & Winter Season

As the season approaches, here’s what to watch for:

• The FDA has approved future vaccines: for fall 2025, vaccines will be monovalent JN.1 lineage formulas to better match circulating strains. U.S. Food and Drug Administration
• ACIP is expected to review and issue updated recommendations — possibly revising eligibility or priority groups again. ABC News+2HHS.gov+2
• Conflicting guidelines among CDC, AAP, ACOG may leave patients and doctors with varying paths to follow. PBS+2TIME+2
• Access, insurance coverage, and legal mandates may diverge across states depending on how each responds to the federal guidance. TIME+1

---

What You Should Do (Personal Guide)

Given the shifting landscape, here are steps you can take:

1. Talk to your healthcare provider
   Because the CDC now emphasizes “shared decision-making,” your risk profile (age, health conditions, exposure) matters more than ever.
2. Get the 2024–2025 updated vaccine if eligible
   If you’re 6 months or older and meet the criteria (especially 65+, immunocompromised, or unvaccinated), it’s recommended. CDC+3CDC+3CDC+3
3. Evaluate need for additional doses if older or immunocompromised
   Two doses for 65+ and possibly a third dose for immunocompromised individuals may be beneficial. CDC+2CDC+2
4. Delay vaccination if you recently had COVID-19
   Wait about 3 months post-infection before getting your next dose. CDC
5. Stay informed about local and state policies
   Because states may override or interpret guidance differently, know your state’s rules.
6. Monitor advisories
   The ACIP meeting, new CDC or FDA statements, and peer-reviewed data will continue to shift policy.

---

Why These Changes Matter

• Insurance & access risks: If the CDC no longer “recommends” for certain groups, insurers might drop coverage or impose co-pays.
• Public trust: Abrupt shifts may weaken confidence in public health guidance.
• Disease burden: Even though COVID severity is lower than peak pandemic years, it still causes hospitalizations — especially in vulnerable populations.
• Global implications: U.S. policy often influences vaccine strategy in many countries.